BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 12960311)

  • 1. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12.
    Inngjerdingen M; Rolstad B; Ryan JC
    J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
    Lowin-Kropf B; Kunz B; Schneider P; Held W
    Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45.
    Mason LH; Willette-Brown J; Taylor LS; McVicar DW
    J Immunol; 2006 Jun; 176(11):6615-23. PubMed ID: 16709819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells.
    George TC; Mason LH; Ortaldo JR; Kumar V; Bennett M
    J Immunol; 1999 Feb; 162(4):2035-43. PubMed ID: 9973475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of IFN-gamma upon triggering of activating Ly49D NK receptors in vitro and in vivo: costimulation with IL-12 or IL-18 overrides inhibitory receptors.
    Ortaldo JR; Young HA
    J Immunol; 2003 Feb; 170(4):1763-9. PubMed ID: 12574340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.
    Regunathan J; Chen Y; Wang D; Malarkannan S
    Blood; 2005 Jan; 105(1):233-40. PubMed ID: 15328154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two structurally related rat Ly49 receptors with opposing functions (Ly49 stimulatory receptor 5 and Ly49 inhibitory receptor 5) recognize nonclassical MHC class Ib-encoded target ligands.
    Naper C; Dai KZ; Kveberg L; Rolstad B; Niemi EC; Vaage JT; Ryan JC
    J Immunol; 2005 Mar; 174(5):2702-11. PubMed ID: 15728478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of a novel activating Ly49 closely related to Ly49A.
    Makrigiannis AP; Gosselin P; Mason LH; Taylor LS; McVicar DW; Ortaldo JR; Anderson SK
    J Immunol; 1999 Nov; 163(9):4931-8. PubMed ID: 10528196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand.
    Matsumoto N; Mitsuki M; Tajima K; Yokoyama WM; Yamamoto K
    J Exp Med; 2001 Jan; 193(2):147-58. PubMed ID: 11148219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NK cell MHC class I receptor Ly49A detects mutations on H-2Dd inside and outside of the peptide binding groove.
    Matsumoto N; Yokoyama WM; Kojima S; Yamamoto K
    J Immunol; 2001 Apr; 166(7):4422-8. PubMed ID: 11254697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation.
    Chalifour A; Roger J; Lemieux S; Duplay P
    Immunology; 2003 May; 109(1):58-67. PubMed ID: 12709018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells.
    Fahlén L; Lendahl U; Sentman CL
    J Immunol; 2001 Jun; 166(11):6585-92. PubMed ID: 11359811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ly-49W, an activating receptor of nonobese diabetic mice with close homology to the inhibitory receptor Ly-49G, recognizes H-2D(k) and H-2D(d).
    Silver ET; Gong D; Hazes B; Kane KP
    J Immunol; 2001 Feb; 166(4):2333-41. PubMed ID: 11160290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the Ly49I natural killer cell receptor reveals variability in dimerization mode within the Ly49 family.
    Dimasi N; Sawicki MW; Reineck LA; Li Y; Natarajan K; Margulies DH; Mariuzza RA
    J Mol Biol; 2002 Jul; 320(3):573-85. PubMed ID: 12096910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of Ly49 family receptors with MHC class I ligands in trans and cis.
    Scarpellino L; Oeschger F; Guillaume P; Coudert JD; Lévy F; Leclercq G; Held W
    J Immunol; 2007 Feb; 178(3):1277-84. PubMed ID: 17237373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.
    Voyle RB; Beermann F; Lees RK; Schümann J; Zimmer J; Held W; MacDonald HR
    J Exp Med; 2003 Apr; 197(7):919-25. PubMed ID: 12682111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A species-specific determinant on beta2-microglobulin required for Ly49A recognition of its MHC class I ligand.
    Mitsuki M; Matsumoto N; Yamamoto K
    Int Immunol; 2004 Feb; 16(2):197-204. PubMed ID: 14734604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells.
    Huntington ND; Xu Y; Nutt SL; Tarlinton DM
    J Exp Med; 2005 May; 201(9):1421-33. PubMed ID: 15867094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of external major histocompatibility complex class I molecules by natural killer cells expressing inhibitory Ly49 receptors.
    Sjöström A; Eriksson M; Cerboni C; Johansson MH; Sentman CL; Kärre K; Höglund P
    J Exp Med; 2001 Nov; 194(10):1519-30. PubMed ID: 11714758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External and internal calibration of the MHC class I-specific receptor Ly49A on murine natural killer cells.
    Kåse A; Johansson MH; Olsson-Alheim MY; Kärre K; Höglund P
    J Immunol; 1998 Dec; 161(11):6133-8. PubMed ID: 9834098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.